Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5185694 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL5185683 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL5185680 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL25389506 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL11913652 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL25391011 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL14472358 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL2535606 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL2535605 | 1.00 | GSR (0.44) | GSRALDH1A1ALOX15 | |
| SCHEMBL5369553 | 0.96 | GSR (0.43) | GSRALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250205374-A1 | METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF AN ISOMER-FREE DIENOPHILE | UNIVERSITY OF COPENHAGEN (DK) | 2025-06-26 | — | — | US | disclosed |
| WO-2025051721-A1 | METHOD FOR RAPID OXIDATION OF DIHYDROPYRIDAZINES TO PYRIDAZINES | UNIVERSITY OF COPENHAGEN (DK) | 2025-03-13 | — | — | WO | disclosed |
| EP-4520751-A1 | METHOD FOR RAPID OXIDATION OF DIHYDROPYRIDAZINES TO PYRIDAZINES | University of Copenhagen (DK) | 2025-03-12 | — | — | EP | disclosed |
| EP-4490136-A1 | METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF AN ISOMER-FREE DIENOPHILE | University of Copenhagen (DK) | 2025-01-15 | — | — | EP | disclosed |
| WO-2023170164-A1 | METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF A SYMMETRICAL DIENE | UNIVERSITY OF COPENHAGEN (DK) | 2023-09-14 | — | — | WO | disclosed |
| WO-2023170174-A1 | METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF AN ISOMER-FREE DIENOPHILE | UNIVERSITY OF COPENHAGEN (DK) | 2023-09-14 | — | — | WO | disclosed |
| US-20230144534-A1 | CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2023-05-11 | — | — | US | disclosed |
| US-20170233365-A1 | CYCLOOCTENES FOR BIOORTHOGONOL REACTIONS | THE GENERAL HOSPITAL CORPORATION | 2017-08-17 | — | — | US | disclosed |
| EP-1235871-B1 | NOVEL REGIO-REGULAR COPOLYMER AND METHODS OF FORMING SAME | CRYOVAC INC (US) | 2007-07-11 | — | — | EP | disclosed |
| US-6506860-B1 | Metathesis ring-opening polymerization | CRYOVAC, INC. | 2003-01-14 | — | — | US | disclosed |
| EP-1235871-A1 | NOVEL REGIO-REGULAR COPOLYMER AND METHODS OF FORMING SAME | Cryovac, Inc. (US) | 2002-09-04 | — | — | EP | disclosed |
| US-6153714-A | FORMED BY RING-OPENING METATHESIS POLYMERIZATION OF A C 7-12 CYCLOALKENE HAVING A VICINAL PAIR OF FUNCTIONAL GROUPS PENDENT FROM RING CARBON ATOMS. | CRYOVAC, INC. (US) | 2000-11-28 | — | — | US | disclosed |
| WO-1999050331-A1 | NOVEL REGIO-REGULAR COPOLYMER AND METHODS OF FORMING SAME | CRYOVAC, INC. (US) | 1999-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230144534-A1 | CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION | KIT, TPSB2, BTD | GSR 2791/4885ALDH1A1 760/4885ALOX15 416/4885 |
| US-20170233365-A1 | CYCLOOCTENES FOR BIOORTHOGONOL REACTIONS | SQLE, BBOX1, TKT | GSR 571/4885ALDH1A1 3535/4885ALOX15 65/4885 |
| US-20250205374-A1 | METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF AN ISOMER-FREE DIENOPHILE | ALDH3A1, SQLE, DUOX1 | GSR 423/4885ALDH1A1 21/4885ALOX15 1018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.